share_log

Pfizer | DEFA14A: Others

Pfizer | DEFA14A: Others

辉瑞 | DEFA14A：其他
SEC announcement ·  04/09 10:34
Moomoo AI 已提取核心信息
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as a vote reminder. This filing, identified as DEFA14A, is part of the Schedule 14A Proxy Statement, which is required under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Pfizer as the registrant, indicating that the company is directly involved in the solicitation of proxies from shareholders. No filing fee was required for this submission. The purpose of these materials is to remind shareholders to vote, an important aspect of corporate governance and shareholder engagement.
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as a vote reminder. This filing, identified as DEFA14A, is part of the Schedule 14A Proxy Statement, which is required under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Pfizer as the registrant, indicating that the company is directly involved in the solicitation of proxies from shareholders. No filing fee was required for this submission. The purpose of these materials is to remind shareholders to vote, an important aspect of corporate governance and shareholder engagement.
辉瑞公司已向美国证券交易委员会（SEC）提交了明确的补充材料作为投票提醒。该文件名为 DEFA14A，是附表14A委托书的一部分，该委托书是1934年《证券交易法》第14（a）条所要求的。这些材料是由辉瑞作为注册人提交的，表明该公司直接参与了向股东征集代理人的活动。本次提交无需缴纳任何申请费。这些材料的目的是提醒股东投票，这是公司治理和股东参与的一个重要方面。
辉瑞公司已向美国证券交易委员会（SEC）提交了明确的补充材料作为投票提醒。该文件名为 DEFA14A，是附表14A委托书的一部分，该委托书是1934年《证券交易法》第14（a）条所要求的。这些材料是由辉瑞作为注册人提交的，表明该公司直接参与了向股东征集代理人的活动。本次提交无需缴纳任何申请费。这些材料的目的是提醒股东投票，这是公司治理和股东参与的一个重要方面。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息